SPARCL1, Shp2, MSH2, E-cadherin, p53, ADCY-2 and MAPK are prognosis-related in colorectal cancer

Table 1 Clinicopathologic data of patients

Terms	n (%)
Sex
Male	85 (54.5)
Female	71 (45.5)
Location
Right hemicolon	45 (30.1)
Transverse colon	3 (1.9)
Left hemicolon	8 (5.8)
Sigmoid colon	32 (20.5)
Rectum	67 (41.7)
Differentiation
Well	95 (60.9)
Moderately	40 (25.6)
Poorly	17 (10.9)
Unknown	4 (2.6)
Bowel wall invasion (pT)
T1	7 (4.5)
T2	30 (19.2)
T3	116 (74.4)
T4	3 (1.9)
Lymph node metastasis (pN)
N0	82 (52.6)
N1	43 (27.5)
N2	31 (19.9)
Distant metastasis (pM)
M0	144 (92.3)
M1	12 (7.7)
TNM staging
I	29 (18.6)
II	52 (33.3)
III	63 (40.4)
IV	12 (7.7)
Post-surgery event
Recurrence or metastasis	51 (32.7)
Survival status
Dead	51 (32.7)1
Alive	105 (67.3)

¹Among patients who have died, 40 patients died from recurrence or metastasis, while 11 patients died from causes such as heart or lung failure, or reasons unknown. TNM: Tumor-nodes-metastasis.